MRPL55 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.273000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.231200E-01
Normal-vs-Stage2
4.648000E-01
Normal-vs-Stage3
7.913000E-01
Normal-vs-Stage4
6.518800E-01
Stage1-vs-Stage2
5.642400E-01
Stage1-vs-Stage3
3.994800E-01
Stage1-vs-Stage4
3.916400E-01
Stage2-vs-Stage3
6.022400E-01
Stage2-vs-Stage4
6.650200E-01
Stage3-vs-Stage4
9.415000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.742000E-01
Normal-vs-AfricanAmerican
2.699400E-01
Normal-vs-Asian
7.570000E-02
Caucasian-vs-AfricanAmerican
5.810000E-01
Caucasian-vs-Asian
1.831590E-01
AfricanAmerican-vs-Asian
5.450600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.100500E-03
Normal-vs-Female
3.946800E-01
Male-vs-Female
4.613800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.560200E-01
Normal-vs-Age(41-60Yrs)
4.666400E-01
Normal-vs-Age(61-80Yrs)
7.223100E-03
Normal-vs-Age(81-100Yrs)
1.845170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.278800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.454200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.219400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.474390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.516400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.602800E-01
Normal-vs-Daily Drinker
2.581800E-01
Normal-vs-Weekly Drinker
7.114000E-02
Normal-vs-Occasional Drinker
3.094200E-01
Normal-vs-Social Drinker
4.184600E-01
Non Drinker-vs-Daily Drinker
5.093000E-01
Non Drinker-vs-Weekly Drinker
2.604400E-01
Non Drinker-vs-Occasional Drinker
8.598600E-01
Non Drinker-vs-Social Drinker
8.007200E-01
Daily Drinker-vs-Weekly Drinker
3.886800E-01
Daily Drinker-vs-Occasional Drinker
6.674800E-01
Daily Drinker-vs-Social Drinker
4.321400E-01
Weekly Drinker-vs-Occasional Drinker
2.963000E-01
Weekly Drinker-vs-Social Drinker
2.282600E-01
Occasional Drinker-vs-Social Drinker
6.961000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.661400E-01
Normal-vs-Grade 2
8.250200E-02
Normal-vs-Grade 3
1.182580E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.773200E-01
Grade 1-vs-Grade 3
3.076000E-01
Grade 1-vs-Grade 4
2.661400E-01
Grade 2-vs-Grade 3
7.101000E-01
Grade 2-vs-Grade 4
8.250200E-02
Grade 3-vs-Grade 4
1.182580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.315400E-01
Normal-vs-NonDiabetic
2.343400E-03
Diabetic-vs-NonDiabetic
1.109610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.543700E-02
Normal-vs-NoPancreatitis
4.220600E-01
Pancreatitis-vs-NoPancreatitis
2.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.457600E-01
Normal-vs-N1
5.426400E-01
N0-vs-N1
6.082400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.158400E-01
Normal-vs-TP53-NonMutant
7.831700E-02
TP53-Mutant-vs-TP53-NonMutant
9.134000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
